JGC
FOMX
J. Goldman & Co’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-168,778
| Closed | -$562K | – | 301 |
|
2019
Q4 | $562K | Buy |
+168,778
| New | +$562K | 0.04% | 139 |
|
2019
Q3 | – | Sell |
-100,000
| Closed | -$238K | – | 295 |
|
2019
Q2 | $238K | Sell |
100,000
-789,000
| -89% | -$1.88M | 0.02% | 153 |
|
2019
Q1 | $3.33M | Buy |
+889,000
| New | +$3.33M | 0.19% | 88 |
|
2018
Q4 | – | Sell |
-104,000
| Closed | -$596K | – | 255 |
|
2018
Q3 | $596K | Buy |
+104,000
| New | +$596K | 0.04% | 125 |
|
2017
Q1 | – | Sell |
-157,700
| Closed | -$1.75M | – | 345 |
|
2016
Q4 | $1.75M | Sell |
157,700
-230,300
| -59% | -$2.56M | 0.12% | 103 |
|
2016
Q3 | $3.59M | Sell |
388,000
-108,547
| -22% | -$1.01M | 0.2% | 79 |
|
2016
Q2 | $3.15M | Sell |
496,547
-72,633
| -13% | -$461K | 0.16% | 81 |
|
2016
Q1 | $3.71M | Sell |
569,180
-10,820
| -2% | -$70.5K | 0.23% | 73 |
|
2015
Q4 | $4.7M | Buy |
580,000
+105,190
| +22% | +$853K | 0.49% | 54 |
|
2015
Q3 | $3.48M | Buy |
474,810
+69,810
| +17% | +$512K | 0.3% | 72 |
|
2015
Q2 | $4.15M | Buy |
+405,000
| New | +$4.15M | 0.25% | 68 |
|